UniDose — Intradermal Drug Delivery

Platform Overview

A new standard for intradermal delivery

UniDose is a next-generation intradermal drug delivery platform designed to overcome the limitations of existing microneedle and injection systems. Our protected approach supports significantly higher payload capacity than current solutions while maintaining simplicity, reliability, and patient comfort.

The platform is compact, thermostable, and compatible with established fill-finish and lyophilization processes, enabling efficient scale-up. By unlocking intradermal delivery for a broad range of therapeutics—including vaccines and large-molecule drugs—UniDose aims to improve access, efficacy, and safety worldwide.

❄

Dry-form delivery

No reconstitution; reduced cold-chain burden.

⌖

Consistent placement

User-independent delivery at controlled depth.

⚙

Made for scale

Compatible with standard fill-finish + lyo.

⧉

Versatile API support

Modular reservoirs for broad therapeutic use.

Illustrative macro view of UniDose device features

Illustrative macro view of device features (non-proprietary).

The Challenge

Current approaches fall short

Biologics and advanced therapeutics often face delivery challenges: variable absorption with subcutaneous injection, inconsistent outcomes with traditional intradermal methods, and manufacturability limits for first-generation patches.

Inconsistent real-world intradermal techniques
Variable absorption for large molecules
Payload and manufacturing constraints

Our Solution

Precise, consistent, scalable

UniDose is a press-and-click intradermal system that ensures consistent placement while remaining patient-friendly and scalable. In a dry (lyophilized) format, medications can be more thermostable, easing cold-chain demands and simplifying distribution.

Reliable dermal delivery — Consistent intradermal deposition.
Thermostable dry-form — Lyophilized medications can reduce cold-chain burden.
Scalable & safe — Compatible with standard manufacturing; no sharps waste.

User-independent Thermostable No sharps waste

UniDose delivery vs classic microneedle patch comparison

Illustrative comparison showing deeper, controlled deposition vs. classic MAP tenting.

Manufacturing

Manufacturing at scale

UniDose aligns with proven pharmaceutical workflows. The modular design integrates into existing aseptic fill-finish and lyophilization processes without costly overhauls.

Drop-in compatibility — Works within standard equipment and infrastructure.
Scalable production — From pilot runs to global volumes.
Quality by design — Built for reproducibility and compliance.

High-level manufacturing flow (non-confidential representation).

Applications

Use Cases

Vaccines

Public-health programs where thermostability and ease of use are critical.

Biologics

Enabling intradermal delivery for large-molecule therapeutics.

Emerging Therapies

Extensible platform for future modalities as evidence develops.

Intradermal delivery, designed for scale.